ALLMedicine™ Transfusion Reactions Center
Research & Reviews 479 results
https://doi.org/10.1111/trf.16967
Transfusion Covington ML, Cone-Sullivan JK et. al.
Jul 3rd, 2022 - Unmasking delayed hemolytic transfusion reactions in patients with sickle-cell disease: Challenges and opportunities for improvement.|2022|Covington ML,Cone-Sullivan JK,Andrzejewski C,Lu W,Thomasson RR,|
https://doi.org/10.1093/labmed/lmac075
Laboratory Medicine; Jacobs JW, Horstman E et. al.
Jul 2nd, 2022 - Bombay phenotype, an exceptionally rare blood type in individuals outside of Southeast Asia, occurs in approximately 1 in 1,000,000 individuals in Europe. This blood phenotype is characterized by the absence of the H antigen on red blood cells (RB...
https://www.ncbi.nlm.nih.gov/pubmed/35777807
Annals of Clinical and Laboratory Science; Yanagisawa R, Yamanaka R et. al.
Jul 2nd, 2022 - Among transfusion-associated adverse reactions, allergic transfusion reactions (ATRs) and febrile non-hemolytic transfusion reactions (FNHTRs) have a particularly high incidence. However, details of their occurrence time and related clinical facto...
https://doi.org/10.1097/SCS.0000000000008648
The Journal of Craniofacial Surgery; Chumble A, Brush P et. al.
Jun 28th, 2022 - Over 90% of patients undergoing cranial vault remodeling for craniosynostosis receive blood transfusions to compensate for intraoperative blood loss. However, transfusions are not without risk and can lead to allergic and immune transfusion reacti...
https://doi.org/10.1002/pbc.29842
Pediatric Blood & Cancer; Wang Y, Sun W et. al.
Jun 28th, 2022 - There are no international standards or normalizations for diagnosing and treating complications from blood transfusions. We comprehensively compared the incidence of adverse blood transfusions in children and adults. Available literature on blood...
Guidelines 2 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6988392
Blood Advances; Chou ST, Alsawas M et. al.
Jan 28th, 2020 - Red cell transfusions remain a mainstay of therapy for patients with sickle cell disease (SCD), but pose significant clinical challenges. Guidance for specific indications and administration of transfusion, as well as screening, prevention, and ma...
https://doi.org/10.1111/trf.14611
Transfusion Compernolle V, Chou ST et. al.
Apr 27th, 2018 - Red blood cell (RBC) transfusions remain essential in the treatment of patients with sickle cell disease (SCD) and β-thalassemia. Alloimmunization, a well-documented complication of transfusion, increases the risk of delayed hemolytic transfusion ...
Drugs 170 results see all →
Clinicaltrials.gov 42 results
https://clinicaltrials.gov/ct2/show/NCT05240391
May 10th, 2022 - Paracentesis-induced circulatory disturbance (PICD) is a very common cause of mortality and morbidity in patients undergoing large-volume paracentesis. Albumin is commonly used in decompensated cirrhosis during large-volume paracentesis. However, ...
https://clinicaltrials.gov/ct2/show/NCT05304442
Apr 8th, 2022 - Iron deficiency anemia (IDA) is the most common hematologic disorder in the United States and worldwide. Patients with moderate to severe anemia often present to the acute care setting for initial assessment and evaluation; women with abnormal ute...
https://clinicaltrials.gov/ct2/show/NCT02314988
Mar 8th, 2022 - Reducing perioperative blood loss is critically important in the treatment of multiply injured combat casualties, and major blood loss during complex spine trauma surgery is a significant concern. Similar to previous studies in dental, cardiac, an...
https://clinicaltrials.gov/ct2/show/NCT04348656
Mar 3rd, 2022 - Problem to be addressed: In December 2019, the Wuhan Municipal Health Committee (Wuhan, China) identified an outbreak of viral pneumonia cases of unknown cause. Coronavirus RNA was quickly identified in some of these patients.This novel coronaviru...
https://clinicaltrials.gov/ct2/show/NCT01499888
Feb 17th, 2022 - Sickle cell disease is an inherited defect caused by a mutation in the Beta globin gene affecting red blood cells. Symptoms begin at 6 months of life and often lead to debilitating vaso-occlusive pain crises, acute insults to vital organ systems,c...
News 35 results
https://www.medscape.com/viewarticle/971657
Apr 6th, 2022 - MANCHESTER — Over a fifth of reported blood transfusion reactions are in patients with sickle cell disease, over half of which involve the potentially life-threatening complication hyperhaemolysis, suggests a UK analysis. "Haemolytic transfusion r...
https://www.onclive.com/view/induction-and-post-induction-therapy-for-adult-all
Apr 2nd, 2021 - Transcript:Bijal D. Shah, MD: Risk stratification in acute lymphoblastic leukemia (ALL) is absolutely the next most important thing we can do to improve outcomes. Now, risk stratification involves, I think, fundamentally two components. The first ...
https://www.onclive.com/view/management-of-cancer-related-anemia-in-2011
Dec 5th, 2020 - Eric H. Kraut, MD Erythropoietin-stimulating agents (ESAs), once considered miracle drugs that enjoyed widespread use for cancer-related anemia, fell into disfavor in 2007, when evidence demonstrated that ESAs decreased survival and time to dise...
https://www.mdedge.com/fedprac/article/232099/myelodysplastic-syndrome/most-transfusion-dependent-mds-patients-report
Nov 18th, 2020 - Key clinical point : Approximately half of transfusion-dependent MDS patients said they had not discussed ways to reduce the need for transfusions with their doctors and 74% said there were no alternatives to blood transfusions. Major finding : Am.
https://www.staging.medscape.com/viewarticle/927716
Mar 28th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. As the proportion of patients infected with COVID-19 continues to rise in the United States, the Food and Drug Administration is facilitating acc...